Skip to content

Ayahuasca: all studies

Page 130 of 167: studies 1,291 to 1,300 of 1,661, newest first. Back to the ayahuasca overview

Research

Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects

Neuroscience of Consciousness 2024 Charlotte Martial, Robin Carhart-Harris, Christopher Timmermann 9 citations

Abstract Mystical-like states of consciousness may arise through means such as psychedelic substances, but may also occur unexpectedly during near-death experiences (NDEs). So far, research studies comparing experiences induced by serotonergic psychedelics and NDEs, along with their enduring effects, have employed between-subject designs, limiting direct comparisons. We present results from an...

DOI: 10.1093/nc/niae033 (opens in new tab) Full text (opens in new tab) Consciousness studies phenomenology Altered states Awareness Impact +8

Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans

Biomedicine & Pharmacotherapy December 31, 2023 David Fabregat-Safont, Alex Gomez-Gomez, Francisco Madrid-Gambin et al.

Psychedelics are classical hallucinogen drugs that induce a marked altered state of consciousness. In recent years, there has been renewed attention to the possible use of classical psychedelics for the treatment of certain mental health disorders. However, further investigation to better understand their biological effects in humans, their mechanism of action, and their metabolism in humans is...

Psychedelic Therapy: A Primer for Primary Care Clinicians – Part I. Historical Perspective and Overview

December 26, 2023 Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas et al. preprint

Background: Psychedelic drugs have recently emerged as plausibly effective pharmacological agents for the management of depression, anxiety, and other neuropsychiatric conditions, including conditions that have not benefited from prior interventions. The latter half of the twentieth century marked a revolution in the treatment of depression, anxiety, and psychosis, exemplified by the...

Facilitating pura medicina

Approaching Religion December 18, 2023 Tero Heinonen 3 citations

In this article, based on my doctoral research, I discuss the appropriation of religious elements from South America by Finnish ‘mystical tourists’. The plant medicine ceremonies are approached as spiritual commodities. Imagining local beliefs and practices as ancient cultural heritage, essentially and authentically spiritual, Finnish mystical tourists adapt these practices for their own...

DOI: 10.30664/ar.131084 (opens in new tab) Mysticism Aesthetics Indigenous Animism +6

N, N-dimethyltryptamine forms oxygenated metabolites via CYP2D6 - an in vitro investigation.

Xenobiotica December 1, 2023 Emma Eckernäs, Alicia Macan-Schönleben, Moa Andresen-Bergström et al. 6 citations

N, N-dimethyltryptamine (DMT) is a psychedelic compound that has shown potential in the treatment of depression. Aside from the primary role of monoamine oxidase A (MAO-A) in DMT metabolism, the metabolic pathways are poorly understood. Increasing this understanding is an essential aspect of ensuring safe and efficacious use of DMT.This work aimed to investigate the cytochrome 450 (CYP)...

DOI: 10.1080/00498254.2023.2278488 (opens in new tab) Full text (opens in new tab) N n-dimethyltryptamine Cytochrome p450 Human liver microsomes In vitro metabolism +6

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.

Psychedelic Medicine December 1, 2023 William Brennan, Alex R. Kelman, Alexander Belser 43 citations

Psychedelic-assisted therapy has gained significant attention in recent years. However, there is a lack of empirical clarity on the role of psychosocial interventions (PIs) in clinical trials of psychedelic treatment due in part to deficiencies in reporting practices found in the existing literature. These PI include non-drug support or interventions provided by psychotherapists or facilitators...

DOI: 10.1089/psymed.2023.0007 (opens in new tab) Full text (opens in new tab) Clinical trials Psychedelic-assisted therapy pat Psychosocial interventions Reporting practices +7

Drug–drug interactions involving classic psychedelics: A systematic review

Journal of Psychopharmacology November 20, 2023 Andreas Halman, Geraldine Kong, Jerome Sarris et al. 42 citations

Classic psychedelics, including lysergic acid diethylamide (LSD), psilocybin, mescaline, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), are potent psychoactive substances that have been studied for their physiological and psychological effects. However, our understanding of the potential interactions and outcomes when using these substances in combination with...

Psychedelia: The interplay of music and psychedelics

Annals of the New York Academy of Sciences November 20, 2023 Katarina Jerotic, Peter Vuust, Morten L. Kringelbach 19 citations

Abstract Music and psychedelics have been intertwined throughout the existence of Homo sapiens , from the early shamanic rituals of the Americas and Africa to the modern use of psychedelic‐assisted therapy for a variety of mental health conditions. Across such settings, music has been highly prized for its ability to guide the psychedelic experience. Here, we examine the interplay between music...

Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis

Journal of Psychoactive Drugs November 15, 2023 Anees Bahji, Isis Lunsky, Gilmar Gutierrez et al. 21 citations

There has been a resurgence in psychedelic research for managing psychiatric conditions in recent years. This study aimed to present a comprehensive review of the current state of the field by applying a systematic search strategy for articles on the effectiveness and tolerability of four psychedelic-assisted therapies (psilocybin, lysergic acid diethylamide [LSD],...

DOI: 10.1080/02791072.2023.2278586 (opens in new tab) Full text (opens in new tab) PTSD Psychedelic-assisted therapies Anxiety disorders Mental health treatment +3

Cardiovascular safety of psychedelic medicine: current status and future directions

Pharmacological Reports October 24, 2023 Agnieszka Wsół 56 citations

Abstract Psychedelics are powerful psychoactive substances that alter perception and mood processes. Their effectiveness in the treatment of psychiatric diseases was known before their prohibition. An increasing number of recent studies, due to the indisputable resurgence of serotonergic hallucinogens, have shown their efficacy in alleviating depression, anxiety, substance abuse therapies, and...